Additional file 2: of 
                     l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia

Jung, Ki; Cho, Su-Hee; Kim, Seok; Ko, Young; Kang, Eun-Suk; Kim, Won

doi:10.6084/m9.figshare.c.3625091_D3.v1

13045_2016_271_MOESM2_ESM.docx (17.83 kB)

Additional file 2: of l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia

journal contribution

posted on 2016-04-18, 05:00 authored by Ki Jung, Su-Hee Cho, Seok Kim, Young Ko, Eun-Suk Kang, Won Kim

Summary of patients who underwent HSCT after SMILE or VIDL chemotherapy. One patient underwent autologous HSCT and 7 patients received allogeneic HSCT. No engraftment failure or treatment-related mortality occurred. But, 2 patients died from disease relapse (Autologous; 1, Allogeneic; 1). (DOCX 17 kb)